Biotech & Digital Health
To be eligible for BEN, a biotech or digital health company must fulfill the following requirements:
Device/Diagnostic:
Stage: beyond prototype with clinical outcome data for reimbursement strategy, validating corporate partnerships, and filed with FDA (or will within 6 months)
Investment: $2 million – $5 million Revenue: $2- $5 million in revenue, sales, or licensing royalties
Biotech/Pharma:
Stage: in clinical trials; and validating corporate partnership in place
Investment: $20 million in one to two rounds
Mobile/Digital Health:
Investment: $2 - 5 million Validation through testing in clinical/healthcare setting
Revenue: $2 - 5 million in revenue, sales, or licensing royalties